Cargando…
Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis
Diethylcarbamazine, the antiparasitic drug, also possesses anti-inflammatory and immunomodulatory activities. The anti-fibrotic activity of diethylcarbamazine makes it a potential candidate to treat coronavirus disease 2019 (COVID-19)-related pulmonary fibrosis. Experimental and clinical studies sho...
Autores principales: | Medina-De la Garza, Carlos Eduardo, Salvador Flores-Torres, Armando, García-Hernández, Marisela, de los Ángeles Castro-Corona, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788098/ https://www.ncbi.nlm.nih.gov/pubmed/35095174 http://dx.doi.org/10.1016/j.mehy.2022.110774 |
Ejemplares similares
-
Visual mnemonics for serum protein electrophoresis
por: Medina-De la Garza, Carlos E., et al.
Publicado: (2013) -
Near misdiagnosis of acute HIV-infection with ELISA-Western Blot scheme: Time for mindset change
por: Medina-De la Garza, Carlos Eduardo, et al.
Publicado: (2021) -
Diethylcarbamazine and Non-Diethylcarbamazine Related Bancroftian Granuloma: An Immunohistochemical Study of Eosinophil Toxic Proteins
por: Figueredo-Silva, Jose, et al.
Publicado: (2010) -
Diethylcarbamazine Attenuates the Development of Carrageenan-Induced Lung Injury in Mice
por: Ribeiro, Edlene Lima, et al.
Publicado: (2014) -
The Diethylcarbamazine Delays and Decreases the NETosis of Polymorphonuclear Cells of Humans with DM Type 2
por: Segoviano-Ramirez, Juan C., et al.
Publicado: (2020)